Gemini-Based Lipoplexes Complement the Mitochondrial Phenotype in MFN1-Knockout Mouse Embryonic Fibroblasts

Area of Science:

• Cell Biology
• Genetics
• Biotechnology

Background:

• Mitochondria are dynamic organelles crucial for cellular function, requiring a balance of division and fusion.
• Mitofusin proteins (Mfn1 and Mfn2) regulate mitochondrial outer membrane fusion; mutations cause dysfunction and mitochondrial diseases (MDs).
• Defective Mfn1 or Mfn2 leads to a fragmented mitochondrial network, a hallmark of cellular dysfunction.

Purpose of the Study:

• To develop a novel gene delivery system for restoring functional Mfn1 in MFN1-knockout cells.
• To investigate the therapeutic potential of GCL/DOPE-DNA lipoplexes for treating mitochondrial diseases.

Main Methods:

• Utilized a biocompatible mixture of synthetic gemini cationic lipids (GCLs) and DOPE to create lipoplexes.
• Complexed and delivered intact MFN1 gene copies into MFN1-Knockout mouse embryonic fibroblasts (MFN1-KO MEFs).
• Assessed Mfn1 levels, mitochondrial network structure, and lipoplex characteristics (hexagonal phase).

Main Results:

• GCL/DOPE-DNA lipoplexes successfully delivered the MFN1 gene, leading to ectopic production of functional Mfn1.
• A four-fold increase in Mfn1 levels was sufficient to revert the MFN1-KO phenotype and partially restore mitochondrial networks.
• Successful phenotype complementation correlated with lipoplexes exhibiting a high proportion of hexagonal phase.

Conclusions:

• GCL/DOPE-DNA lipoplexes are effective agents for delivering the MFN1 gene and restoring mitochondrial function.
• This approach shows significant promise as a therapeutic strategy for mitochondrial diseases caused by Mfn1 deficiency.
• The hexagonal phase characteristics of the lipoplexes are linked to their transfection efficiency and therapeutic efficacy.